Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $823.38 | 54 | 99.8% |
| Education | $1.31 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $145.49 | 11 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $119.37 | 8 | $0 (2024) |
| Allergan Inc. | $91.98 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $50.13 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $49.10 | 3 | $0 (2022) |
| Becton, Dickinson and Company | $48.79 | 2 | $0 (2019) |
| Mylan Specialty L.P. | $34.28 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $33.48 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $31.81 | 2 | $0 (2023) |
| Amgen Inc. | $30.58 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $198.60 | 12 | Novartis Pharmaceuticals Corporation ($50.13) |
| 2023 | $92.65 | 6 | E.R. Squibb & Sons, L.L.C. ($28.32) |
| 2022 | $72.95 | 5 | E.R. Squibb & Sons, L.L.C. ($40.74) |
| 2021 | $61.43 | 4 | PFIZER INC. ($26.25) |
| 2020 | $42.02 | 3 | PFIZER INC. ($27.73) |
| 2019 | $147.94 | 10 | PFIZER INC. ($64.44) |
| 2018 | $181.74 | 12 | Allergan Inc. ($63.42) |
| 2017 | $27.36 | 3 | GlaxoSmithKline, LLC. ($13.35) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/04/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Nephrology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Bone Health | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Fresenius USA Marketing, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Nephrology | ||||||
| 08/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Bone Health | ||||||
| 05/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: Cardiovascular | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardio-renal | ||||||
| 02/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.00 | General |
| Category: Cardiovascular | ||||||
| 10/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: DIABETES | ||||||
| 09/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Cardiovascular | ||||||
| 08/11/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Cardiovascular | ||||||
| 04/29/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Oncology | ||||||
| 11/09/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Cardiovascular | ||||||
| 07/08/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: Cardiovascular | ||||||
| 07/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardio-renal | ||||||
| 04/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.34 | General |
| Category: Cardiovascular | ||||||
| 12/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,475 | 2,746 | $659,404 | $250,610 |
| 2022 | 11 | 1,235 | 2,443 | $453,165 | $186,641 |
| 2021 | 15 | 1,522 | 3,080 | $582,594 | $234,605 |
| 2020 | 13 | 1,565 | 3,225 | $711,842 | $250,830 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 28 | 245 | $144,766 | $53,567 | 37.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 185 | 744 | $135,408 | $43,911 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 384 | 430 | $58,050 | $40,848 | 70.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 447 | 567 | $57,400 | $33,502 | 58.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 12 | 95 | $61,069 | $20,747 | 34.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 115 | $58,880 | $14,829 | 25.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 70 | $46,060 | $10,926 | 23.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 39 | 115 | $27,715 | $6,121 | 22.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 50 | 50 | $10,200 | $6,099 | 59.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 40 | 107 | $10,486 | $3,939 | 37.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 40 | $13,840 | $3,661 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 33 | 33 | $5,367 | $3,065 | 57.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 34 | $8,942 | $3,019 | 33.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 12 | 43 | $12,685 | $2,730 | 21.5% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 11 | 13 | $5,191 | $1,951 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 45 | $3,345 | $1,697 | 50.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 28 | 256 | $116,480 | $58,056 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 492 | 773 | $78,070 | $50,060 | 64.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 164 | 568 | $103,376 | $29,653 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 212 | 239 | $14,331 | $10,012 | 69.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 85 | 98 | $33,908 | $9,521 | 28.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 56 | $28,672 | $7,945 | 27.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 51 | 125 | $30,125 | $6,651 | 22.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 90 | 228 | $22,344 | $6,329 | 28.3% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 14 | 50 | $14,750 | $3,281 | 22.2% |
About Bed Chhatkuli
Bed Chhatkuli is a Internal Medicine healthcare provider based in Hays, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1770727810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bed Chhatkuli has received a total of $824.69 in payments from pharmaceutical and medical device companies, with $198.60 received in 2024. These payments were reported across 55 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($823.38).
As a Medicare-enrolled provider, Chhatkuli has provided services to 5,797 Medicare beneficiaries, totaling 11,494 services with total Medicare billing of $922,687. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Hays, KS
- Active Since 04/20/2009
- Last Updated 03/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770727810
Products in Payments
- ELIQUIS (Drug) $185.14
- CAMZYOS (Drug) $79.72
- AVYCAZ (Drug) $65.12
- ENTRESTO (Drug) $35.35
- FASENRA (Drug) $33.48
- EVENITY (Biological) $30.58
- Kerendia (Drug) $30.39
- CFN PLEURX (Device) $28.01
- TEFLARO (Drug) $26.86
- XARELTO (Drug) $21.31
- CFN PleurX (Device) $20.78
- NUCALA (Biological) $20.71
- YUPELRI (Drug) $20.15
- BELSOMRA (Drug) $19.11
- NXSTAGE SYSTEM ONE (Device) $18.02
- REMODULIN (Drug) $16.28
- VRAYLAR (Drug) $16.17
- LIBERTY SELECT CYCLER (Device) $15.39
- BENLYSTA (Biological) $15.04
- LEQVIO (Drug) $14.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hays
Dr. Jacob Morgan, Md, MD
Internal Medicine — Payments: $34,968
Dr. Kent Gleed, M.d, M.D
Internal Medicine — Payments: $24,972
Travis Haneke, Md, MD
Internal Medicine — Payments: $19,169
Dr. Shanon Custer, Md, MD
Internal Medicine — Payments: $8,167
Anthony Accurso, Md, MD
Internal Medicine — Payments: $5,702
Dr. Jeffery Curtis, M.d, M.D
Internal Medicine — Payments: $2,733